Related Experiment Video
Updated: Jun 5, 2025

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Thyrotoxic Periodic Paralysis: A Unique Case Highlighting the Diagnostic Challenges and Management
Jawad Atrash1, Tariq Musleh1, Yazan Naji1
1Internal Medicine Department, Saint Joseph Hospital, Jerusalem, PSE.
Abstract:
Thyrotoxic periodic paralysis (TPP) is a rare complication primarily associated with thyrotoxicosis, particularly in individuals with Graves' disease. While more common in males aged 20 to 40, it can occur across all ethnic backgrounds. It is the most common type of acquired periodic paralysis. The condition is triggered by factors like exercise, stress, diet, and certain medications. The diagnosis is confirmed by severe hypokalemia and elevated thyroid hormones in the presence of acute flaccid paralysis. Immediate treatment involves correcting hypokalemia, while long-term management focuses on normalizing thyroid levels. In this article, we will report a case of a 30-year-old Middle Eastern man who presented to the emergency room with severe muscle weakness following extensive exertion and a high-carbohydrate diet. Physical examination revealed motor weakness in all limbs, particularly his lower limbs. Initial tests showed marked hypokalemia and biochemical thyrotoxicosis with suppressed thyroid-stimulating hormone (TSH) and elevated free triiodothyronine (T3) and free thyroxine (T4). An electrocardiogram (ECG) indicated signs of severe hypokalemia with an atrioventricular (AV) block. After he was diagnosed with TPP, the patient received oral and intravenous potassium infusions and was started on anti-thyroid medications, most importantly beta (β)-blockers. Following acute treatment, his potassium levels normalized, and he regained full muscle function. Ultimately, he was maintained on anti-thyroid medications at discharge to maintain an euthyroid state in order to prevent future recurrences of symptoms. Consequently, in patients presenting with acute flaccid paralysis, potassium level, and thyroid function should be investigated in order to promptly diagnose complications of thyrotoxicosis and to start an early appropriate combined therapy. The early and rapid management of TPP can prevent serious cardiopulmonary complications.
More Related Videos
11:46Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model
Published on: October 13, 2022
08:16Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model
Published on: February 11, 2019
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Depolarizing Blockers: Pharmocokinetics
Acute Pancreatitis II: Clinical Manifestations and Management
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...